<?xml version="1.0" encoding="UTF-8"?>
<p>Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new emerging fatal disease emerged in Wuhan, China in December 2019.
 <xref rid="jmv25754-bib-0001" ref-type="ref">
  <sup>1</sup>
 </xref>, 
 <xref rid="jmv25754-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref> This is the third CoV epidemic after SARS and Middle East respiratory syndrome (MERS) CoV outbreaks. Initial phylogenetic analysis indicates the formation of a common cluster with bat SARS‐like CoV isolated in 2015.
 <xref rid="jmv25754-bib-0003" ref-type="ref">
  <sup>3</sup>
 </xref> Structural studies showed the close relation of the receptor‐binding domain of SARS‐CoV‐2 with SARS CoV.
 <xref rid="jmv25754-bib-0004" ref-type="ref">
  <sup>4</sup>
 </xref> Three major CoV epidemics were evolved during the past few decades. The first epidemic was SARS CoV in 2003.
 <xref rid="jmv25754-bib-0005" ref-type="ref">
  <sup>5</sup>
 </xref> Evidence was provided that SARS CoV was raised from an animal source including an intermediate host animal, which transmitted the virus from a bat carrier to humans.
 <xref rid="jmv25754-bib-0006" ref-type="ref">
  <sup>6</sup>
 </xref> About a decade later, MERS CoV was first identified in the Arabian Peninsula.
 <xref rid="jmv25754-bib-0007" ref-type="ref">
  <sup>7</sup>
 </xref> Lastly, in December 2019, the third epidemic emerged in Wuhan, China.
</p>
